Circulation, Vol 71, 466-472, Copyright © 1985 by American Heart Association
H Schwartz, RL Leiboff, RJ Katz, AG Wasserman, GB Bren, PJ Varghese and AM Ross
To better characterize the changes in left ventricular ejection fraction
after myocardial infarction, we compared radionuclide ventriculograms
obtained acutely and 2 weeks after acute myocardial infarction in 40
patients. These patients underwent angiography within a mean of 4 hr and 20
min after the onset of symptoms of infarction and either received no
therapy (32 patients who were control subjects in a thrombolysis trial) or
did not experience reperfusion (eight patients) despite receiving
streptokinase infusions. In all 40 patients, the change in left ventricular
ejection fraction over 2 weeks was small (+2.6%). Patients were then
grouped according to the presence or absence of residual flow on their
angiograms. Residual flow was considered to be present in 21 patients, in
12 by virtue of subtotal occlusion of the artery supplying the area of
infarct and in nine because of well-developed coronary collaterals to the
distal infarct artery. Mean change in ejection fraction for patients with
residual flow was +6.9 +/- 2.3% vs -2.2 +/- 1.7% for patients without
residual flow (p less than .01). Fourteen of 21 (67%) patients with
residual flow had a spontaneous rise in ejection fraction of greater than
5%, as compared with two of 19 (11%) patients without residual flow (p less
than .01). Time to peak level of creatine kinase (CK) was significantly
shorter in the residual flow group (15 vs 23 hr, p less than .01), while
the peak level of CK was lower (1550 vs 2220 IU) in these patients. This
latter difference did not reach statistical significance (p =
.10).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Arteriographic predictors of spontaneous improvement in left ventricular function after myocardial infarction
This article has been cited by other articles:
![]() |
N. van Royen, J. J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease Cardiovasc Res, February 16, 2001; 49(3): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Goncalves Angiogenic growth factors: potential new treatment for acute myocardial infarction? Cardiovasc Res, January 14, 2000; 45(2): 294 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Piek, R. A. M. van Liebergen, K. T. Koch, R. J. de Winter, R. J. G. Peters, and G. K. David Pharmacological Modulation of the Human Collateral Vascular Resistance in Acute and Chronic Coronary Occlusion Assessed by Intracoronary Blood Flow Velocity Analysis in an Angioplasty Model Circulation, July 1, 1997; 96(1): 106 - 115. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |